Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.

Guloksuz S, Arts B, Walter S, Drukker M, Rodriguez L, Myint AM, Schwarz MJ, Ponds R, van Os J, Kenis G, Rutten BP.

Brain Behav Immun. 2015 Mar 9. pii: S0889-1591(15)00072-0. doi: 10.1016/j.bbi.2015.02.029. [Epub ahead of print]

PMID:
25765557
2.

Comparative Study of Clinical and Neuropsychological Characteristics Between Early-, Late and Very-Late-Onset Schizophrenia-Spectrum Disorders.

Hanssen M, van der Werf M, Verkaaik M, Arts B, Myin-Germeys I, van Os J, Verhey F, Köhler S; Genetic Risk and Outcome in Psychosis study group.

Am J Geriatr Psychiatry. 2014 Nov 4. pii: S1064-7481(14)00317-0. doi: 10.1016/j.jagp.2014.10.007. [Epub ahead of print]

PMID:
25500119
3.

Epigenetic effects of electroconvulsive seizures.

de Jong JO, Arts B, Boks MP, Sienaert P, van den Hove DL, Kenis G, van Os J, Rutten BP.

J ECT. 2014 Jun;30(2):152-9. doi: 10.1097/YCT.0000000000000141. Review.

PMID:
24810773
4.

The immune system and electroconvulsive therapy for depression.

Guloksuz S, Rutten BP, Arts B, van Os J, Kenis G.

J ECT. 2014 Jun;30(2):132-7. doi: 10.1097/YCT.0000000000000127. Review.

PMID:
24755720
5.

Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability.

Guloksuz S, Wichers M, Kenis G, Russel MG, Wauters A, Verkerk R, Arts B, van Os J.

PLoS One. 2013;8(3):e60435. doi: 10.1371/journal.pone.0060435. Epub 2013 Mar 27.

6.

Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158 Met genotype.

Arts B, Simons CJ, Drukker M, van Os J.

BMC Psychiatry. 2013 Feb 19;13:63. doi: 10.1186/1471-244X-13-63.

7.

Evidence for the impact of the CACNA1C risk allele rs1006737 on 2-year cognitive functioning in bipolar disorder.

Arts B, Simons CJ, Os Jv.

Psychiatr Genet. 2013 Feb;23(1):41-2. doi: 10.1097/YPG.0b013e328358641c. No abstract available.

PMID:
22914618
8.

Cognitive processes and attitudes in bipolar disorder: a study into personality, dysfunctional attitudes and attention bias in patients with bipolar disorder and their relatives.

Jabben N, Arts B, Jongen EM, Smulders FT, van Os J, Krabbendam L.

J Affect Disord. 2012 Dec 20;143(1-3):265-8. doi: 10.1016/j.jad.2012.04.022. Epub 2012 Jul 25.

PMID:
22840633
9.

Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.

Jabben N, Arts B, van Os J, Krabbendam L.

J Clin Psychiatry. 2010 Jun;71(6):764-74. doi: 10.4088/JCP.08m04837yel. Epub 2010 Jan 26.

PMID:
20122370
10.

Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.

Jabben N, Arts B, Krabbendam L, van Os J.

Bipolar Disord. 2009 Mar;11(2):166-77. doi: 10.1111/j.1399-5618.2009.00663.x.

PMID:
19267699
11.

Attentional bias and general orienting processes in bipolar disorder.

Jongen EM, Smulders FT, Ranson SM, Arts BM, Krabbendam L.

J Behav Ther Exp Psychiatry. 2007 Jun;38(2):168-83. Epub 2006 Nov 14.

PMID:
17107657
12.

S100 and impact of ECT on depression and cognition.

Arts B, Peters M, Ponds R, Honig A, Menheere P, van Os J.

J ECT. 2006 Sep;22(3):206-12.

PMID:
16957538
13.

Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review.

Krabbendam L, Arts B, van Os J, Aleman A.

Schizophr Res. 2005 Dec 15;80(2-3):137-49. Epub 2005 Sep 23.

PMID:
16183257
14.

Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility.

Pelsers MM, Hanhoff T, Van der Voort D, Arts B, Peters M, Ponds R, Honig A, Rudzinski W, Spener F, de Kruijk JR, Twijnstra A, Hermens WT, Menheere PP, Glatz JF.

Clin Chem. 2004 Sep;50(9):1568-75. Epub 2004 Jun 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk